查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1737256

全球醫療保健生物微機電系統 (BioMEMS) 和微系統市場 - 市場規模（按類型、應用、地區、預測）

Global BioMEMS And Microsystem In Healthcare Market Size By Type, By Application, By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

醫療領域生物MEMS及微系統的市場規模及預測

2024 年醫療保健生物微機電系統和微系統市場規模價值 59 億美元，預計到 2032 年將達到 137 億美元，預測期內（2026-2032 年）的複合年成長率為 13.20%。

行動醫療應用需求的日益成長，以及有助於疾病早期診斷和降低死亡率的病患監測設備的市場發展，將在預測期內推動全球醫療生物微機電系統 (BioMEMS) 和微系統市場的發展。此外，生物微機電系統 (BioMEMS) 在建立全球健康應用方面的日益廣泛應用，對於理解生物系統至關重要，而各種生物微機電系統 (BioMEMS) 應用的普及，很可能在未來一年推動全球市場的成長。 《全球醫療生物微機電系統 (BioMEMS) 和微系統市場報告》對市場進行了全面的評估，對關鍵細分市場、趨勢、市場促進因素、市場限制、競爭格局以及影響市場的關鍵因素進行了全面的分析。

定義醫療保健領域生物微機電系統 (BioMEMS) 和微系統的全球市場

具有生物或生物醫學功能的MEMS稱為BioMEMS。 MEMS是一種將生物分子作為關鍵組件的醫療設備。 醫療設備在醫療產業中用於監控壓力、溫度和運動，傳輸光學和電子數據，以及操控微型元件。

生物微機電系統 (BioMEMS) 是用於生物醫學研究和醫療應用的微機電系統 (MEMS) 裝置的子類型。生物微機電系統將微型感測器、致動器、微光學裝置、微流體裝置和結構組件與電腦和控制系統整合在一起。醫療產業的微系統用途廣泛。這些裝置能夠提升醫療設備的效能，為醫療設備醫療設備製造商帶來競爭優勢。加速計利用 MEMS 和奈米技術改善了心臟治療和藥物傳輸。

BioMEMS 設備可植入人體特定部位，提供個人化藥物治療。藥物傳遞系統可在藥物注射體內時調節劑量，進而增強藥物療效，同時最大程度降低副作用風險。 BioMEMS 設備中的感測器利用特定的標記分子追蹤藥物的釋放曲線和療效。這些指標有助於醫生了解所治療疾病是否正在進展。加速計、陀螺儀、壓力感測器、麥克風、超音波感測器、流量計、光學 MEMS/MOEMS、熱電堆、氣體感測器和微流體是 BioMEMS 的一些最常見應用。

醫療保健市場概覽

預計全球醫療生物微機電系統 (BioMEMS) 和微系統市場將在預測期內取得顯著發展。生物微機電系統和微系統在臨床和生物應用中發揮著不可或缺的作用，它們能夠監測一些最緊迫的健康相關問題，例如醫療成本和疾病預防技術。此外，生物微機電系統的出現為升級目前僅限於被動擴散裝置的經皮給藥系統提供了巨大的潛力，從而推動市場成長。此外，有助於檢測疾病早期症狀以降低死亡率的病患監測設備的發展也將進一步推動市場成長。

此外，醫療成本的不斷上漲，也使得對相對實惠的健康監測設備的需求不斷成長，這些設備可以取代傳統的定期體檢。感測器可以安裝在家中的各個角落，監測日常活動並報告任何異常情況。這類感測器還可用於及時監測患者健康狀況，提供準確可靠的數據，幫助評估患者的健康狀況。這項技術有望惠及老年人群，使他們能夠定期接受體檢並獲得及時支持。從而推動全球醫療領域生物微機電系統 (BioMEMS) 和微系統市場的成長。

此外，微技術的進步，加上基因組學、蛋白質組學和生物技術方法的最新趨勢，為生物微機電系統 (BioMEMS) 設備應用開闢了全新且令人著迷的可能性。這些設備能夠實現新的生物感測、分子識別和監測、藥物傳輸、實驗室晶片技術以及利用微技術建構的未來生物醫學和生物系統。因此，這項技術進步將為全球生物微機電系統和微系統市場在醫療保健領域帶來新的機會。然而，由於開發成本高以及產品開發週期長且難以被廣泛接受，全球生物微機電系統和微系統市場預計將受到限制。

此外，對 BioMEMS 的認知度低將阻礙市場成長。

此外，突如其來的新冠肺炎疫情對全球產業造成了不利影響。生物微機電系統（MEMS）和微系統製造企業正在重新思考其長期策略，以期在疫情後提升競爭力。為了因應供應鏈中斷、需求波動等一連串挑戰，企業正在調整策略，調整產品系列組成、資本投入、研發策略、併購策略等。

目錄

第1章：醫療健康領域生物MEMS與微系統的全球市場簡介

  • 市場概覽
  • 研究範圍
  • 先決條件

第2章執行摘要

第3章：已驗證的市場研究調查方法

  • 資料探勘
  • 驗證
  • 第一手資料
  • 資料來源列表

第4章全球生物MEMS與醫療微系統市場展望

  • 概述
  • 市場動態
    • 驅動程式
    • 限制因素
    • 機會
  • 波特五力模型
  • 價值鏈分析

第5章全球醫療保健領域生物MEMS和微系統市場（按類型）

  • 概述
  • 生物微機電系統
  • 微系統

第6章 醫療保健領域生物MEMS和微系統的全球市場（按應用）

  • 概述
  • 微流體
  • 用於藥物輸送的微型分配器
  • 低電平表
  • 其他

第7章全球醫療生物MEMS和微系統市場（按地區）

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 世界其他地區
    • 拉丁美洲
    • 中東和非洲

第8章全球醫療保健生物MEMS與微系統市場的競爭格局

  • 概述
  • 各公司市場排名
  • 主要發展策略

第9章 公司簡介

  • Bluechiip
  • Cepheid
  • Given Imaging
  • Integrated Sensing
  • Boston Scientific
  • Becton Dickinson and Co（BD）
  • Heimann Sensor
  • CapitalBio
  • Lepu Medical Technology
  • Nanopass Technologies

第10章 附錄

  • 相關調查
簡介目錄
Product Code: 59296

BioMEMS And Microsystem In Healthcare Market Size And Forecast

BioMEMS And Microsystem In Healthcare Market size was valued at USD 5.9 Billion in 2024 and is projected to reach USD 13.7 Billion by 2032, growing at a CAGR of 13.20 % during the forecast period 2026-2032.

The growing need for mobile care applications, and the development of patient monitoring equipment that aids in the early diagnosis of disease indications and therefore lowers mortality rates, will propel the global BioMEMS And Microsystem In Healthcare Market forward over the anticipated period. In addition, the expanding use of BioMEMS in creating global health & applications essential for understanding biological systems, and the availability of a wide range of BioMEMS applications, are likely to fuel global market growth over the coming year. The Global BioMEMS And Microsystem In Healthcare Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global BioMEMS And Microsystem In Healthcare Market Definition

MEMS with biological or biomedical functions are known as BioMEMS or biomedical microelectromechanical systems. MEMS are medical gadgets that incorporate live molecules as a critical component. MEMS are medical devices that include living molecules as an essential element of the device. Medical devices that contain biological molecules as an integral part of the device are known as MEMS. MEMS are utilized in the medical industry to monitor pressures, temperatures, and movement, transfer optical and electronic data carry fluids, and operate a micro-size component, among other functions.

BioMEMS is the subtype of MEMS devices utilized in biomedical research and medical applications. BioMEMS integrates microscopic sensors, actuators, micro-optics, microfluidics, and structural components with a computer and control system. Microsystems in the healthcare industry are used for various purposes. These devices increase the performance of medical equipment by giving medical device producers a competitive advantage. Accelerometers have improved cardiac disease treatment, as has the use of MEMS and nanotechnology to improve drug delivery.

The BioMEMS device can be implanted in a specific area of the body to administer personalized medication therapy. The delivery system takes over and regulates the dose when the medication is delivered into the body, enhancing the drug's effectiveness while minimizing the risk of side effects. The sensors in BioMEMS devices track the drug's release profile and effectiveness using specific marker molecules. These indicators can help doctors figure out if the disease they're treating has advanced. Accelerometers, gyroscopes, pressure, microphones, ultrasound, Flowmeters, Optical MEMS/MOEMS, Thermopiles, Gas sensors, and Microfluidics are some of the most common applications for BioMEMS.

Healthcare Market Overview

The global BioMEMS And Microsystem In Healthcare Market are expected to observe notable progress over the forecasted period. BioMEMS and microsystems play an essential role in clinical and biological applications by monitoring some of the most pressing health-related issues, such as healthcare costs and disease prevention techniques. Additionally, with the advent of BioMEMS devices, there is a massive potential for upgrading transdermal drug delivery systems, which are now confined to passive diffusion devices, resulting in market growth. Moreover, the development of patient monitoring equipment that helps in detecting early symptoms of diseases, to reduce the mortality rate will further propel the market growth.

Furthermore, the rising healthcare costs have necessitated the increase in demand for health monitoring equipment, which is a comparatively more affordable alternative to traditional routine check-ups. Sensors can be placed throughout a home to monitor daily activities and report on any odd changes. Sensors of this type are also used for monitoring unwell patients in a timely manner. It gives accurate and dependable data that aids in the assessment of one's health. This technology has the potential to benefit the elderly population by allowing them to receive frequent exams and prompt support. Thus, driving the growth of the global BioMEMS And Microsystem In Healthcare Market.

Also that, the advancement of microtechnology, combined with recent developments in genomics, proteomics, and biotechnology approaches, has opened up new and intriguing possibilities for BioMEMS device applications. These gadgets will enable new biosensing, molecular identification and monitoring, medication delivery, lab-on-a-chip technologies, and futuristic biomedical and biological systems using microtechnology. Thus, the Advancing Technologies will open up new opportunities for the global BioMEMS And Microsystem In Healthcare Market. However, the global BioMEMS And Microsystem In Healthcare Market are anticipated to be restrained by a lack of acceptance due to high development costs and extensive and long product development cycles.

Additionally, the lack of awareness about BioMEMS will hamper the growth of the market.

Furthermore, the unexpected emergence of covid 19 pandemics has a negative impact on the global industry. Companies that make BioMEMS and Microsystems are rethinking their long-term strategy in order to be more competitive in the aftermath of the COVID outbreak. Companies are revising their strategies in response to a slew of challenges, including supply chain disruptions, demand fluctuations, and other pressing concerns, by changing the composition of product portfolios, capital investment, Research & Development strategies, acquisitions & mergers, and other policies.

Global BioMEMS And Microsystem In Healthcare Market: Segmentation Analysis

The Global BioMEMS And Microsystem In Healthcare Market is Segmented on the basis of Type, Application, and Geography.

BioMEMS And Microsystem In Healthcare Market, By Type

  • BioMEMS
  • Microsystem

Based on Type, the BioMEMS And Microsystem In Healthcare Market is bifurcated into BioMEMS and Microsystem. The BioMEMS segment dominates the global market and is expected to grow further during the forecasted period owing to the rising use of BioMEMS in the healthcare industry. Also, the use of BioMEMS for patient care, patient monitoring, IVD scanning, medical imagining, drug delivery, and pharmaceutical research is contributing to the market growth.

BioMEMS And Microsystem In Healthcare Market, By Application

  • Microfluidics
  • Micro Dispensers for Drug Delivery
  • Low Meters
  • Others

Based on Application, the BioMEMS And Microsystem In Healthcare Market is bifurcated into Microfluidics, Micro Dispensers for Drug Delivery, Low Meters, and Others. The microfluidic segment dominates the global BioMEMS And Microsystem In Healthcare Market owing to the increased use of microfluidics in healthcare applications.

BioMEMS And Microsystem In Healthcare Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world
  • On the basis of regional analysis, the Global BioMEMS And Microsystem In Healthcare Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The North American region dominated the global BioMEMS And Microsystem In Healthcare Market in healthcare mainly due to the increasing demand for lifestyle products for health monitoring. In addition, the Asia Pacific region is expected to witness significant growth during the forecasted period, owing to the growing need for patient monitoring equipment for the early diagnosis of disease.

Key Players

The "Global BioMEMS And Microsystem In Healthcare Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Bluechiip, Cepheid, Given Imaging, Integrated Sensing, Boston Scientific, Becton Dickinson and Co (BD), Heimann Sensor, CapitalBio, Lepu Medical Technology, and Nanopass Technologies.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL BIOMEMS AND MICROSYSTEM IN HEALTHCARE MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL BIOMEMS AND MICROSYSTEM IN HEALTHCARE MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL BIOMEMS AND MICROSYSTEM IN HEALTHCARE MARKET, BY TYPE

  • 5.1 Overview
  • 5.2 BioMEMS
  • 5.3 Microsystem

6 GLOBAL BIOMEMS AND MICROSYSTEM IN HEALTHCARE MARKET, BY APPLICATION

  • 6.1 Overview
  • 6.2 Microfluidics
  • 6.3 Micro Dispensers for Drug Delivery
  • 6.4 Low Meters
  • 6.5 Others

7 GLOBAL BIOMEMS AND MICROSYSTEM IN HEALTHCARE MARKET, BY GEOGRAPHY

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 U.K.
    • 7.3.3 France
    • 7.3.4 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Rest of Asia Pacific
  • 7.5 Rest of the World
    • 7.5.1 Latin America
    • 7.5.2 Middle East and Africa

8 GLOBAL BIOMEMS AND MICROSYSTEM IN HEALTHCARE MARKET COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market Ranking
  • 8.3 Key Development Strategies

9 COMPANY PROFILES

  • 9.1 Bluechiip
    • 9.1.1 Overview
    • 9.1.2 Financial Performance
    • 9.1.3 Product Outlook
    • 9.1.4 Key Developments
  • 9.2 Cepheid
    • 9.2.1 Overview
    • 9.2.2 Financial Performance
    • 9.2.3 Product Outlook
    • 9.2.4 Key Developments
  • 9.3 Given Imaging
    • 9.3.1 Overview
    • 9.3.2 Financial Performance
    • 9.3.3 Product Outlook
    • 9.3.4 Key Developments
  • 9.4 Integrated Sensing
    • 9.4.1 Overview
    • 9.4.2 Financial Performance
    • 9.4.3 Product Outlook
    • 9.4.4 Key Developments
  • 9.5 Boston Scientific
    • 9.5.1 Overview
    • 9.5.2 Financial Performance
    • 9.5.3 Product Outlook
    • 9.5.4 Key Developments
  • 9.6 Becton Dickinson and Co (BD)
    • 9.6.1 Overview
    • 9.6.2 Financial Performance
    • 9.6.3 Product Outlook
    • 9.6.4 Key Developments
  • 9.7 Heimann Sensor
    • 9.7.1 Overview
    • 9.7.2 Financial Performance
    • 9.7.3 Product Outlook
    • 9.7.4 Key Developments
  • 9.8 CapitalBio
    • 9.8.1 Overview
    • 9.8.2 Financial Performance
    • 9.8.3 Product Outlook
    • 9.8.4 Key Developments
  • 9.9 Lepu Medical Technology
    • 9.9.1 Overview
    • 9.9.2 Financial Performance
    • 9.9.3 Product Outlook
    • 9.9.4 Key Developments
  • 9.10 Nanopass Technologies
    • 9.10.1 Overview
    • 9.10.2 Financial Performance
    • 9.10.3 Product Outlook
    • 9.10.4 Key Developments

10 Appendix

  • 10.1 Related Research